KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $9.67.

  • Cme Group's EPS (Weighted Average and Diluted) fell 0.40% to $2.49 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.32, marking a year-over-year increase of 8.52%. This contributed to the annual value of $9.67 for FY2024, which is 9.14% up from last year.
  • Latest data reveals that Cme Group reported EPS (Weighted Average and Diluted) of $9.67 as of FY2024, which was up 9.14% from $8.86 recorded in FY2023.
  • Over the past 5 years, Cme Group's EPS (Weighted Average and Diluted) peaked at $9.67 during FY2024, and registered a low of $5.87 during FY2020.
  • Over the past 3 years, Cme Group's median EPS (Weighted Average and Diluted) value was $8.86 (recorded in 2023), while the average stood at $8.64.
  • As far as peak fluctuations go, Cme Group's EPS (Weighted Average and Diluted) fell by 0.68% in 2020, and later grew by 24.19% in 2021.
  • Over the past 5 years, Cme Group's EPS (Weighted Average and Diluted) (Yearly) stood at $5.87 in 2020, then grew by 24.19% to $7.29 in 2021, then grew by 1.51% to $7.40 in 2022, then rose by 19.73% to $8.86 in 2023, then rose by 9.14% to $9.67 in 2024.